Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Interest Expenses (2019 - 2025)

Pulmonx (LUNG) has disclosed Interest Expenses for 7 consecutive years, with $805000.0 as the latest value for Q3 2025.

  • Quarterly Interest Expenses fell 9.65% to $805000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Sep 2025, down 9.58% year-over-year, with the annual reading at $3.5 million for FY2024, 8.51% up from the prior year.
  • Interest Expenses for Q3 2025 was $805000.0 at Pulmonx, up from $799000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $904000.0 in Q4 2023, with the low at $198000.0 in Q1 2022.
  • Average Interest Expenses over 5 years is $579947.4, with a median of $781000.0 recorded in 2025.
  • The sharpest move saw Interest Expenses plummeted 81.23% in 2021, then soared 287.44% in 2023.
  • Over 5 years, Interest Expenses stood at $199000.0 in 2021, then surged by 80.4% to $359000.0 in 2022, then soared by 151.81% to $904000.0 in 2023, then decreased by 6.86% to $842000.0 in 2024, then fell by 4.39% to $805000.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $805000.0, $799000.0, and $781000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.